Literature DB >> 18770043

Effect of religiosity and spirituality on drug treatment outcomes.

Bradley T Conner1, M Douglas Anglin, Jeffery Annon, Douglas Longshore.   

Abstract

This study empirically tested one component of a comprehensive model of the role of religiosity and spirituality (R/S) in drug treatment that is presented as a companion article in this special issue. Data collected from individuals dependent on heroin receiving narcotic replacement therapy were used to assess the effects of R/S on drug treatment outcomes. Based on their R and S scores, participants were assigned to one of four groups: those whose scores remained consistently high across the 12-month study period were compared to those whose scores were consistently low, increased, or decreased across the same period. Results indicated that at both study completion (12 months after admission) and 6 months after that participants in the consistently high and increasing spirituality groups self-reported significantly fewer days of heroin and cocaine/crack use than those in the consistently low group (p < 0.05). There were no significant differences among the religiosity groups on self-reported heroin or cocaine/crack use. Results from chi(2) analyses indicated that at 12 months the results of urinalysis for the presence of opiates, but not cocaine/crack, were dependent on spirituality group membership (p < 0.01) but not religiosity group membership. Results also indicated that at the 6-month follow-up, there were significantly more participants in the decreasing group who were not in maintenance treatment who had a positive urinalysis and fewer in the increasing group than would be expected if the two variables were independent (p < 0.05). Implications for addictions health services are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18770043      PMCID: PMC2693037          DOI: 10.1007/s11414-008-9145-z

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  7 in total

1.  Looking back on cocaine dependence: reasons for recovery.

Authors:  Patrick M Flynn; George W Joe; Kirk M Broome; D Dwayne Simpson; Barry S Brown
Journal:  Am J Addict       Date:  2003 Oct-Dec

2.  Spiritually and religiously oriented health interventions.

Authors:  A H Harris; C E Thoresen; M E McCullough; D B Larson
Journal:  J Health Psychol       Date:  1999-05

Review 3.  Are religiosity and spirituality useful constructs in drug treatment research?

Authors:  Douglas Longshore; M Douglas Anglin; Bradley T Conner
Journal:  J Behav Health Serv Res       Date:  2008-11-21       Impact factor: 1.505

Review 4.  The religion-health connection: evidence, theory, and future directions.

Authors:  C G Ellison; J S Levin
Journal:  Health Educ Behav       Date:  1998-12

Review 5.  Researching the spiritual dimensions of alcohol and other drug problems.

Authors:  W R Miller
Journal:  Addiction       Date:  1998-07       Impact factor: 6.526

6.  The use of religious coping during stressful life events: main effects, moderation, and mediation.

Authors:  A P Tix; P A Frazier
Journal:  J Consult Clin Psychol       Date:  1998-04

7.  Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.

Authors:  Douglas Longshore; Jeffrey Annon; M Douglas Anglin; Richard A Rawson
Journal:  Addiction       Date:  2005-08       Impact factor: 6.526

  7 in total
  10 in total

1.  The Religious and Spiritual Dimensions of Cutting Down and Stopping Cocaine Use: A Qualitative Exploration Among African Americans in the South.

Authors:  Ann M Cheney; Geoffrey M Curran; Brenda M Booth; Steve Sullivan; Katharine Stewart; Tyrone F Borders
Journal:  J Drug Issues       Date:  2014-01

Review 2.  Are religiosity and spirituality useful constructs in drug treatment research?

Authors:  Douglas Longshore; M Douglas Anglin; Bradley T Conner
Journal:  J Behav Health Serv Res       Date:  2008-11-21       Impact factor: 1.505

3.  Introduction to the special issue on addiction health services: in memory of Douglas Longshore.

Authors:  Christine E Grella; M Douglas Anglin
Journal:  J Behav Health Serv Res       Date:  2008-12-10       Impact factor: 1.505

4.  A preliminary 6-month prospective study examining self-reported religious preference, religiosity/spirituality, and retention at a Jewish residential treatment center for substance-related disorders.

Authors:  Iman Parhami; Margarit Davtian; Michael Collard; Jean Lopez; Timothy W Fong
Journal:  J Behav Health Serv Res       Date:  2014-07       Impact factor: 1.505

5.  Priming effects of self-reported drinking and religiosity.

Authors:  Lindsey M Rodriguez; Clayton Neighbors; Dawn W Foster
Journal:  Psychol Addict Behav       Date:  2013-03-25

Review 6.  Advancing our understanding of religion and spirituality in the context of behavioral medicine.

Authors:  Crystal L Park; Kevin S Masters; John M Salsman; Amy Wachholtz; Andrea D Clements; Elena Salmoirago-Blotcher; Kelly Trevino; Danielle M Wischenka
Journal:  J Behav Med       Date:  2016-06-24

7.  Religiosity as a Predictor of Adolescents' Substance Use Disorder Treatment Outcomes.

Authors:  Julie D Yeterian; Krisanne Bursik; John F Kelly
Journal:  Subst Abus       Date:  2014-09-15       Impact factor: 3.716

8.  Healthcare Providers' Perceptions about the Role of Spiritual Care and Chaplaincy Services in Substance Use Outpatient Treatment.

Authors:  Brian S W Earl; Anne Klee; Ellen L Edens; James D Cooke; Holly Heikkila; Lauretta E Grau
Journal:  Int J Environ Res Public Health       Date:  2022-08-01       Impact factor: 4.614

9.  "God put weed here for us to smoke": A mixed-methods study of religion and spirituality among adolescents with cannabis use disorders.

Authors:  Julie D Yeterian; Krisanne Bursik; John F Kelly
Journal:  Subst Abus       Date:  2018-10-08       Impact factor: 3.716

10.  Faith-based intervention, change of religiosity, and abstinence of substance addicts.

Authors:  Jerf W K Yeung
Journal:  Braz J Psychiatry       Date:  2022 Jan-Feb       Impact factor: 2.697

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.